Critical Care Management of a 17-Year-Old Patient with Homozygous POLG Mitochondrial Disorder
Medical – Clinical – Research · 31.07.2026 · 2 (7)
DOI: 10.52106/3069-9088.1027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical – Clinical – Research, online erschienen am 31.07.2026. Verfasst von Munikumar Chembeti.
Abstract (Originalsprache)
A 17-year-old male with a history of asthma and dyspraxia presented with recurrent tonic-clonic episodes rapidly progressing to refractory status epilepticus (RSE). Standard management was of limited effectiveness. Analysis of laboratory data suggested mitochondrial disease, and genetic sequencing confirmed a homozygous pathogenic variant in the polymerase gamma (POLG) gene (c.1399G>A; p.Ala467Thr). A combination of non-traditional agents ultimately provided seizure control, as conventional antiepileptic drugs like sodium valproate were strictly contraindicated. Tracheostomy became necessary due to profound muscle weakness. Furthermore, the patient’s age, sitting right on the threshold of adulthood, placed him in a challenging category for practical matters of consent and clinical categorization.
Zitieren
APA
Chembeti, M. (2026). Critical Care Management of a 17-Year-Old Patient with Homozygous POLG Mitochondrial Disorder. Medical – Clinical – Research, 2(7). https://doi.org/10.52106/3069-9088.1027
Vancouver
Chembeti M. Critical Care Management of a 17-Year-Old Patient with Homozygous POLG Mitochondrial Disorder. Medical – Clinical – Research. 2026;2(7). doi:10.52106/3069-9088.1027
BibTeX
@article{Chembeti2026,
author = {Chembeti, Munikumar},
title = {Critical Care Management of a 17-Year-Old Patient with Homozygous POLG Mitochondrial Disorder},
journal = {Medical – Clinical – Research},
year = {2026},
volume = {2},
number = {7},
doi = {10.52106/3069-9088.1027}
}
EUVIMED